1. Home
  2. NWGL vs SNTI Comparison

NWGL vs SNTI Comparison

Compare NWGL & SNTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NWGL
  • SNTI
  • Stock Information
  • Founded
  • NWGL 2008
  • SNTI 2016
  • Country
  • NWGL Macau
  • SNTI United States
  • Employees
  • NWGL N/A
  • SNTI N/A
  • Industry
  • NWGL
  • SNTI Biotechnology: Pharmaceutical Preparations
  • Sector
  • NWGL
  • SNTI Health Care
  • Exchange
  • NWGL Nasdaq
  • SNTI Nasdaq
  • Market Cap
  • NWGL 19.9M
  • SNTI 19.1M
  • IPO Year
  • NWGL 2023
  • SNTI N/A
  • Fundamental
  • Price
  • NWGL $1.30
  • SNTI $4.67
  • Analyst Decision
  • NWGL
  • SNTI Strong Buy
  • Analyst Count
  • NWGL 0
  • SNTI 1
  • Target Price
  • NWGL N/A
  • SNTI $12.00
  • AVG Volume (30 Days)
  • NWGL 8.5K
  • SNTI 115.8K
  • Earning Date
  • NWGL 11-29-2024
  • SNTI 11-14-2024
  • Dividend Yield
  • NWGL N/A
  • SNTI N/A
  • EPS Growth
  • NWGL N/A
  • SNTI N/A
  • EPS
  • NWGL N/A
  • SNTI N/A
  • Revenue
  • NWGL $21,707,613.00
  • SNTI N/A
  • Revenue This Year
  • NWGL N/A
  • SNTI $11.52
  • Revenue Next Year
  • NWGL N/A
  • SNTI $78.57
  • P/E Ratio
  • NWGL N/A
  • SNTI N/A
  • Revenue Growth
  • NWGL N/A
  • SNTI N/A
  • 52 Week Low
  • NWGL $1.04
  • SNTI $1.52
  • 52 Week High
  • NWGL $21.97
  • SNTI $16.94
  • Technical
  • Relative Strength Index (RSI)
  • NWGL 54.56
  • SNTI 56.65
  • Support Level
  • NWGL $1.09
  • SNTI $3.72
  • Resistance Level
  • NWGL $1.35
  • SNTI $4.93
  • Average True Range (ATR)
  • NWGL 0.08
  • SNTI 0.46
  • MACD
  • NWGL 0.02
  • SNTI 0.01
  • Stochastic Oscillator
  • NWGL 82.26
  • SNTI 81.82

About NWGL Nature Wood Group Limited

Nature Wood Group Ltd is a vertically-integrated forestry company that focuses on FSC business operations. It produces various products, including logs, decking, flooring, sawn timber, recycled charcoal, synthesized charcoal, machine-made charcoal, and essential oils. The Group owns natural forest concessions and cutting rights for exploiting timbers on parcels of land in Peru. The Group is organized into two operating divisions; Direct Purchase and Original Design Manufacturer (ODM) Services, and Manufacturing segments. The Direct Purchase and ODM Segment that derives the majority of revenue engages in the business of sourcing live wood and owning designed designs on wood products for sales to end customers. Geographically, the company generates a majority of its revenue from China.

About SNTI Senti Biosciences Inc.

Senti Biosciences Inc is a clinical-stage biotechnology company developing next-generation cell and gene therapies engineered with their gene circuit platform technologies to fight challenging diseases. The product candidates utilize allogeneic chimeric antigen receptor natural killer (CAR-NK) cells outfitted with its gene circuit technologies in various oncology indications. The company product candidates include SENTI-202, a Logic Gated off-the-shelf CAR-NK cell therapy designed to target and eliminate cancer cells while sparing the healthy bone marrow; and SENTI-301A for the treatment of hepatocellular carcinoma.

Share on Social Networks: